$6.750
-0.413 (-6.12%)收盘时
ATHA 同业对比
In the context of the broader market, ATHA competes directly with industry leaders such as SNTI and PLUR. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, ATHA's gross margin of N/A stands against SNTI's N/A and PLUR's 33.53%. Such benchmarking helps identify whether LeonaBio Inc is trading at a premium or discount relative to its financial performance.
Financials
FY2025Q3
YoY:
-73.04%
-6.87M
Operating Profit
FY2025Q3
YoY:
-77.00%
-6.61M
Net Income after Tax
FY2025Q3
YoY:
-77.48%
-1.68
EPS - Diluted
FY2025Q3
YoY:
-79.72%
-4.67M
Free Cash Flow
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。